NYSE:HIMS Hims & Hers Health (HIMS) Stock Price, News & Analysis $20.64 -0.12 (-0.58%) (As of 11/5/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends About Hims & Hers Health Stock (NYSE:HIMS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Hims & Hers Health alerts:Sign Up Key Stats Today's Range$19.54▼$22.2850-Day Range$13.65▼$23.5952-Week Range$6.23▼$25.74Volume41.68 million shsAverage Volume8.49 million shsMarket Capitalization$4.43 billionP/E Ratio258.03Dividend YieldN/APrice Target$20.50Consensus RatingModerate Buy Company OverviewHims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.Read More… Elon knows the truth, which is why they want him silenced (Ad)Elon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration. Watch this new documentary and you’ll discover what Elon knows, Hims & Hers Health Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks60th Percentile Overall ScoreHIMS MarketRank™: Hims & Hers Health scored higher than 60% of companies evaluated by MarketBeat, and ranked 711th out of 969 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.3 / 5Analyst RatingModerate Buy Consensus RatingHims & Hers Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 8 buy ratings, 8 hold ratings, and no sell ratings.Amount of Analyst CoverageHims & Hers Health has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Hims & Hers Health's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth68.18% Earnings GrowthEarnings for Hims & Hers Health are expected to grow by 68.18% in the coming year, from $0.22 to $0.37 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Hims & Hers Health is 258.03, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 130.17.Price to Earnings Ratio vs. SectorThe P/E ratio of Hims & Hers Health is 258.03, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 106.46.Price to Book Value per Share RatioHims & Hers Health has a P/B Ratio of 12.82. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Hims & Hers Health's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted18.32% of the float of Hims & Hers Health has been sold short.Short Interest Ratio / Days to CoverHims & Hers Health has a short interest ratio ("days to cover") of 3.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Hims & Hers Health has recently increased by 28.72%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldHims & Hers Health does not currently pay a dividend.Dividend GrowthHims & Hers Health does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted18.32% of the float of Hims & Hers Health has been sold short.Short Interest Ratio / Days to CoverHims & Hers Health has a short interest ratio ("days to cover") of 3.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Hims & Hers Health has recently increased by 28.72%, indicating that investor sentiment is decreasing significantly. News and Social Media3.7 / 5News Sentiment0.57 News SentimentHims & Hers Health has a news sentiment score of 0.57. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.44 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 51 news articles for Hims & Hers Health this week, compared to 13 articles on an average week.Search Interest68 people have searched for HIMS on MarketBeat in the last 30 days. This is an increase of 19% compared to the previous 30 days.MarketBeat Follows41 people have added Hims & Hers Health to their MarketBeat watchlist in the last 30 days. This is an increase of 242% compared to the previous 30 days. Company Ownership3.3 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Hims & Hers Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $15,148,890.00 in company stock.Percentage Held by Insiders17.71% of the stock of Hims & Hers Health is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions63.52% of the stock of Hims & Hers Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Hims & Hers Health's insider trading history. Receive HIMS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Hims & Hers Health and its competitors with MarketBeat's FREE daily newsletter. Email Address HIMS Stock News HeadlinesHims & Hers Health, Inc. (NYSE:HIMS) Insider Soleil Boughton Sells 2,339 SharesOctober 30, 2024 | insidertrades.comTop 3 Stocks Institutions Are Buying Right Now (HIMS)Despite the stock market trading at new all-time highs, institutions still find enough reason to buy more enormous stakes in three stocks.October 28, 2024 | marketbeat.comThis is treasonIf you missed it, my emergency election broadcast is now available - but will be removed soonNovember 5, 2024 | Porter & Company (Ad)Hims & Hers Health, Inc. (NYSE:HIMS) Insider Sells $166,500.00 in StockOctober 23, 2024 | insidertrades.comHims & Hers Health, Inc. (NYSE:HIMS) Insider Sells $47,738.99 in StockOctober 17, 2024 | insidertrades.comHims Reports Strong Earnings, Novo Nordisk Copycat Drug Coming in 2025November 5 at 4:31 PM | investopedia.comPalantir, Trump Media, Hims & Hers Health, NXP Semiconductors, And Tesla: Why These 5 Stocks Are On Investors' Radars TodayNovember 5 at 10:34 AM | benzinga.comHims & Hers Health Reports Better-Than-Expected Q3 Results: DetailsNovember 5 at 10:34 AM | benzinga.comSee More Headlines HIMS Stock Analysis - Frequently Asked Questions How have HIMS shares performed this year? Hims & Hers Health's stock was trading at $8.90 at the start of the year. Since then, HIMS stock has increased by 131.9% and is now trading at $20.64. View the best growth stocks for 2024 here. How were Hims & Hers Health's earnings last quarter? Hims & Hers Health, Inc. (NYSE:HIMS) posted its quarterly earnings data on Monday, November, 4th. The company reported $0.32 earnings per share for the quarter, topping the consensus estimate of $0.06 by $0.26. Hims & Hers Health's revenue for the quarter was up 77.1% compared to the same quarter last year. Who are Hims & Hers Health's major shareholders? Hims & Hers Health's top institutional investors include IMC Chicago LLC, Carnegie Investment Counsel (0.14%), Principal Financial Group Inc. (0.14%) and QRG Capital Management Inc. (0.08%). Insiders that own company stock include Melissa Baird, David B Wells, Alex Bard, Michael Chi, Patrick Harrison Carroll, Soleil Boughton, Oluyemi Okupe, Jules A Maltz, Christopher D Payne, Andrew Dudum, Christiane Pendarvis, Irene Becklund, Lynne Chou O'keefe and Jack Abraham. View institutional ownership trends. How do I buy shares of Hims & Hers Health? Shares of HIMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Hims & Hers Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that Hims & Hers Health investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), Palantir Technologies (PLTR), Netflix (NFLX) and Palo Alto Networks (PANW). Company Calendar Last Earnings11/04/2024Today11/05/2024Fiscal Year End12/31/2024Next Earnings (Estimated)2/24/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Offices & clinics of medical doctors Sub-IndustryHealthcare Current SymbolNYSE:HIMS CUSIPN/A CIK1773751 Webwww.forhims.com Phone415-851-0195FaxN/AEmployees1,046Year FoundedN/APrice Target and Rating Average Stock Price Target$20.71 High Stock Price Target$28.00 Low Stock Price Target$10.00 Potential Upside/Downside-3.3%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage16 Analysts Profitability EPS (Most Recent Fiscal Year)$0.08 Trailing P/E Ratio265.16 Forward P/E Ratio96.41 P/E GrowthN/ANet Income$-23,550,000.00 Net Margins1.70% Pretax Margin1.98% Return on Equity5.25% Return on Assets4.06% Debt Debt-to-Equity RatioN/A Current Ratio2.68 Quick Ratio2.30 Sales & Book Value Annual Sales$872 million Price / Sales5.22 Cash FlowN/A Price / Cash FlowN/A Book Value$1.61 per share Price / Book13.17Miscellaneous Outstanding Shares214,790,000Free Float176,747,000Market Cap$4.56 billion OptionableOptionable Beta1.06 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report This page (NYSE:HIMS) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredMissed Out On Nvidia?Artificial Intelligence is a tool with the potential to create massive distributions of wealth… In fact, it...Unstoppable Prosperity | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThis company will win the AI race Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally c...Porter & Company | SponsoredHow high could Bitcoin go?Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hims & Hers Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hims & Hers Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.